Clinical Study
Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled Study
Table 2
Changes in serum FT3 and FT4 levels during treatment with 15 mg/day OD-MMI and 15 mg/day DD-MMI.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are demonstrated as mean ± standard deviation. 15 mg/day OD-MMI, 15 mg/day of methimazole administered once daily; 15 mg/day DD-MMI, 15 mg/day of methimazole administered dividedly in 5 mg three times a day. No significant difference in all parameters between the two groups. |